HMG-1 shRNA Plasmid (h) from Santa Cruz Biotechnology, Inc.

Product Specs
ItemHMG-1 shRNA Plasmid (h)
CompanySanta Cruz Biotechnology, Inc.
Price $592.00Supplier Page View Company Product Page
Catalog Numbersc-37982-SH
Quantity20 µg
RNA TypeshRNA Clones
Vector Type (Standardized)Lentiviral
TypeshRNA Plasmid
Specieshuman
NCBI Full Gene Namehigh mobility group box 1
NCBI Gene AliasesHMG-1, HMG1, HMG3, SBP-1

Add to Compare List

Santa Cruz Biotechnology, Inc.

10410 Finnell Street

Dallas, Texas 75220

United States

Phone: 1-800-457-3801
831-457-3801

Company Profile

Website: http://www.scbt.com/

(1) Mechanistic investigation of HMGB1 in an in vitro model of the trigeminovascular system under migraine-like conditionsThe Journal of Headache and PainApril 11, 2026Maomei Song, Angelica Barone, Suiyi Xu, Changxin Li, Giuseppe Gigli, Giacomo Frati, Cherubino Di Lorenzo, Gianluca Coppola, Barbara Cortese(siRNA) was used for gene silencing. HMGB1-targeting siRNA (siHMGB1) was purchased from Santa Cruz (sc-37982). SH-SY5Y cells were seeded in 6-well plates at a density of 2 × 105 cells per well and incubated overnight

(2) Endothelial specific deletion of HMGB1 increases blood pressure and retards ischemia recovery through eNOS and ROS pathway in miceRedox biologyMay 1, 2021Zhou Q, Tu T, Tai S, Tang L, Yang H, Zhu Z.

(3) miR-142-3p reduces the viability of human cervical cancer cells by negatively regulating the cytoplasmic localization of HMGB1Experimental and therapeutic medicineMarch 1, 2021Dong H, Song J.expression was assessed and cell proliferation assays were performed. Additionally, HMGB1 shRNA(h) (cat. no. sc-37982-SH) and control shRNA (cat. no. sc-108060) were purchased from Santa Cruz Biotechnology, Inc. Transfection

(4) Astragaloside IV antagonizes M2 phenotype macrophage polarization-evoked ovarian cancer cell malignant progression by suppressing the HMGB1-TLR4 axisMolecular immunologyFebruary 1, 2021Wang X, Gao S, Song L, Liu M, Sun Z, Liu J.

(5) HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancerAmerican journal of cancer researchJanuary 1, 2021Jung AR, Kim GE, Kim MY, Ha US, Hong SH, Lee JY, Kim SW, Park YH.

(6) High mobility group box 1 induces bone pain associated with bone invasion in a mouse model of advanced head and neck cancerOncology reportsDecember 1, 2020Nakamura T, Okui T, Hasegawa K, Ryumon S, Ibaragi S, Ono K, Kunisada Y, Obata K, Masui M, Shimo T, et al.(#326052233) was purchased from Shino-Test. Control shRNA plasmid-A (#sc-108060), HMG-1 shRNA plasmid (#sc-37982-SH), and anti-RAGE antibody (anti-mouse, monoclonal, sc-80652) were purchased from Santa Cruz Biotechnology, Inc

(7) HMGB1 mediates lipopolysaccharide-induced inflammation via interacting with GPX4 in colon cancer cellsCancer cell internationalJanuary 1, 2020Yang Y, Yang L, Jiang S, Yang T, Lan J, Lei Y, Tan H, Pan K.

(8) High Mobility Group Box 1 (HMGB1) Predicts Invasion and Poor Prognosis of Glioblastoma Multiforme via Activating AKT Signaling in an Autocrine PathwayMedical science monitor : international medical journal of experimental and clinical researchDecember 9, 2018Cheng P, Ma Y, Gao Z, Duan L.

(9) HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsyMolecular medicine reportsApril 1, 2018Shi Y, Zhang L, Teng J, Miao W.

(10) Indinavir Plus Methylprednisolone Ameliorates Experimental Acute Lung Injury In Vitro and In VivoShock (Augusta, Ga.)February 1, 2018Ji Y, Zhang G, Zhu H, Li D, Jiang W.

(11) MicroRNA-410-3p attenuates gemcitabine resistance in pancreatic ductal adenocarcinoma by inhibiting HMGB1-mediated autophagyOncotargetDecember 8, 2017Xiong J, Wang D, Wei A, Ke N, Wang Y, Tang J, He S, Hu W, Liu X.

(12) High-mobility group box-1 contributes tumor angiogenesis under interleukin-8 mediation during gastric cancer progressionCancer scienceAugust 1, 2017Chung HW, Lim JB.

(13) Hypoxia mediates mitochondrial biogenesis in hepatocellular carcinoma to promote tumor growth through HMGB1 and TLR9 interactionHepatology (Baltimore, Md.)July 1, 2017Tohme S, Yazdani HO, Liu Y, Loughran P, van der Windt DJ, Huang H, Simmons RL, Shiva S, Tai S, Tsung A.

(14) Novel involvement of miR-522-3p in high-mobility group box 1-induced prostaglandin reductase 1 expression and reduction of phagocytosisBiochimica et biophysica acta. Molecular cell researchApril 1, 2017Kang GJ, Lee HJ, Byun HJ, Kim EJ, Kim HJ, Park MK, Lee CH.

(15) GFRA1 promotes cisplatin-induced chemoresistance in osteosarcoma by inducing autophagyAutophagyJanuary 2, 2017Kim M, Jung JY, Choi S, Lee H, Morales LD, Koh JT, Kim SH, Choi YD, Choi C, Slaga TJ, et al.

(16) HMGB1 induces human non-small cell lung cancer cell motility by activating integrin αvβ3/FAK through TLR4/NF-κB signaling pathwayBiochemical and biophysical research communicationsNovember 25, 2016Zhu J, Luo J, Li Y, Jia M, Wang Y, Huang Y, Ke S.

(17) Long Non-coding RNA BGas Regulates the Cystic Fibrosis Transmembrane Conductance RegulatorMolecular therapy : the journal of the American Society of Gene TherapyAugust 1, 2016Saayman SM, Ackley A, Burdach J, Clemson M, Gruenert DC, Tachikawa K, Chivukula P, Weinberg MS, Morris KV.

(18) Combined targeting of high-mobility group box-1 and interleukin-8 to control micrometastasis potential in gastric cancerInternational journal of cancerOctober 1, 2015Chung HW, Jang S, Kim H, Lim JB.

(19) Protective roles of pulmonary rehabilitation mixture in experimental pulmonary fibrosis in vitro and in vivoBrazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicasJune 1, 2015Zhang L, Ji YX, Jiang WL, Lv CJ.

(20) Transcriptional regulation of Mcl-1 plays an important role of cellular protective effector of vincristine-triggered autophagy in oral cancer cellsExpert opinion on therapeutic targetsApril 1, 2015Hsieh MJ, Hsieh YH, Lin CW, Chen MK, Yang SF, Chiou HL.

Be the First to Write a Review!